Organophosphate poisoning by self-injection is rare. Current case report
describes a man with subcutaneous self-injected OP. poisoning presenting
with delayed. He was treated with pralidoxime. Through the observation,
dose and the time between poisoning until time to start treatment we can
conclude different presentations and outcomes of OP poisoning.